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Abstract
Phytochemical studies performed on 4 Indonesian epiphytic medicinal plants, Drynaria rigidula L., Hydnophytum formicarum 
Jack, Usnea misaminensis (Vain) Motyka, and Calymperes schmidtii Broth., revealed 11 known secondary metabolites (1-11), 
reported from these species for the first time. The methanol extracts and their fractions were screened against infective 
agents and cancer cells. The dichloromethane fractions of H. formicarum, U. misaminensis, and C. schmidtii showed activity 
against lung cancer cells with IC50 values of 35, 11, and 20 µg/mL, respectively.
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The archipelago of Indonesia is rich in medicinal plants 
including the neglected subset of epiphytic medicinal plants.1 
Our previous studies revealed the chemical constituents, and 
their corresponding activities, from the rhizome of the 
Indonesian epiphytic fern Drynaria rigidula L.2 Here we 
report on the continued phytochemical investigations into 
Indonesian epiphytic species including the leaves of D. 
rigidula, and further, the whole plant of Hydnophytum formi-
carum Jack, an epiphytic lichen Usnea misaminensis (Vain) 
motyka and an epiphytic bryophyte Calymperes schmidtii 
Broth (Figure 1). The indigenous people of Indonesia have 
claimed the medicinal benefits of these species including D. 
rigidula to treat eye infection, a decocted pith of H. formi-
carum drunken to alleviate swellings and headache, whereas 
U. misaminensis was traditionally used to treat fever, dysen-
tery, inflammation, and hypertension. Usnea was claimed to 
have astringent, diuretic, antiflatulent, and anti-inflammatory 
activities and the decocted plant was prescribed to treat diar-
rhea and dysentery, aphthous ulcers, and abdominal disten-
tion.3 Calymperes schmidtii is part of the nonvascular plant 
group, bryophytes, which consists of approximately 21 000 
species, of which only 2% have been phytochemically stud-
ied.4,5 Compared to common medicinal plants, medicinal 
uses of bryophytes are less common with reported traditional 
uses of mosses including the external use of a poultice of 
Calymperes sp. as insecticidal agent.6 These epiphytes reside 
in moist, dense clusters, which are likely to harvest microbes, 
and, therefore, these species may produce antimicrobial sec-
ondary metabolites. The limited reports of phytochemical 
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data analyzing these medicinal epiphytic plant, therefore, 
lead to this current investigation focusing on the chemical 
and bioactivity investigations of the extracts and fractions of 
these epiphytes. Specifically, we tested a range of biological 
activities; as examples, against Plasmodium falciparum 
given its prevalence in the region as well as the possibility of 
this microorganism being responsible for some of the symp-
toms treated in traditional medicine in the region, and against 
Mycobacterium tuberculosis as a surrogate for antimicrobial 
activity as well as being a microbe in which new treatments 
are still being investigated. We also tested against herpes 
simplex virus type 1, cancer cell lines, and cytoxicity 
testing.
The phytochemical studies on these 4 Indonesian epiphytic 
medicinal plants resulted in the isolation of 11 secondary 
metabolites (Figure 2). The hexane fraction from the crude 
extract of the leaves of D. rigidula produced 3 major secondary 
metabolites, namely campesterol 1, stigmasterol 2, and 
β-sitosterol 3. The molecular structures were deduced by com-
parison of their electron impact mass spectra against the NIST 
standard reference database. The corresponding dichlorometh-
ane fraction was subjected to silica column chromatography 
followed by semipreparative high-performance liquid chroma-
tography (HPLC), and resulted in the isolation of compound 
4.2 A separate semipreparative HPLC protocol was applied to 
the ethyl acetate fraction and the residue and gave 2 isolates, 
which were characterized as kaempferol-3,7-di-O-α-l-rhamn-
opyranoside 42 and kaempferol-7-O-α-l-rhamnopyrano-
syl-4′-O-glucopyranoside 5 (spectral data supplied in 
Supplemental material).7 Compound 4 was also found in a 
5-fold lower yield in our previous investigation of the rhizome 
D. rigidula (1.63 mg/g sample).2
Phytochemical investigations into the hexane fraction 
from the initial methanol extract of H. formicarum pro-
duced 2 sterols stigmast-4-en-3-one 68 and β-sitosterol 3,9 
and the aniline derivative 4-aminophenyl acetate 7 (spec-
tral data supplied in Supplemental material). This is the 
first report of these 3 compounds being isolated from this 
species. Further analyses on the dichloromethane fraction 
were constrained due to limited yield. Analysis of the 
HPLC chromatogram of the brown shiny ethyl acetate 
fraction indicated no discernable peaks, even after back 
extraction with both acid and base.
The n-hexane fraction from the initial methanol extract of 
U. misaminensis produced pale yellow crystals, which were 
identified as usnic acid 8,10 with a second crop obtained follow-
ing back extraction with dichloromethane. Extraction with 
ethyl acetate followed by semipreparative HPLC resulted in 
the isolation and identification of salazinic acid 911 as a white 
needle crystals. The structures of 8 and 9 were confirmed by 
X-ray crystallographic analysis (Figure 3) (spectral data sup-
plied in Supplemental material).
Usnic acid and salazinic acid have been reported to pos-
sess antibacterial activities12,13 with the latter having inhibi-
tory activity against the inflammation regulator, microsomal 
prostaglandin E2 synthase-1.
14 These outcomes support the 
Figure 1. Indonesian epiphytic medicinal plants. (a Drynaria 
rigidula L, b Hynophytum formicarum jack, c Usnea misaminensis 
(Vain) Motyka and d Calymperes schmidtii broth.)
Figure 2. Secondary metabolites isolated from 4 Indonesian 
epiphytic medicinal plants, Drynaria rigidula (1-3, 4, 5), Hynophytum 
formicarum (3, 6, 7), Usnea misaminensis (8, 9), Calymperes schmidtii 
(10, 11).
Figure 3. Oak ridge thermal-ellipsoid plot program drawing of 
usnic acid 8 and salazinic acid 9.
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traditional claims of the Indonesian indigenous population 
with the use of U. misaminensis in infective-related dysen-
tery and inflammation therapy.
Undertaking phytochemical studies on the moss C. schmid-
tii was challenging due to the limited availability of biomass. 
Therefore, its isolation protocol was simplified with the defat-
ted crude extract directly subjected to semipreparative HPLC. 
A gradient eluent from 100% to 0% of solvent A (solvent A, 
0.1% trifluoroacetic acid [TFA] in water; solvent B, 0.1% TFA 
in acetonitrile) within 80 minutes led to the isolation of 2 ben-
zoic acid derivatives at retention times of 39 and 43 minutes. 
These major constituents (Figure 2) were assigned as methyl 
2,4-dihydroxy-3,6-dimethylbenzoate 10,15 and methyl 
2,4-dihydroxy-6-methylbenzoate 11,16 and this is the first 
report of these compounds being isolated from an epiphytic 
moss species (spectral data supplied in Supplemental material). 
It is the reported active component of the commercial herbal 
medicine Tadenan, which is used in therapy for benign prostate 
hyperplasia and in combination therapy for prostate cancer. 
Further studies revealed that the acid 10 inhibited prostate 
cancer cell growth, acting as an antagonist of the human andro-
gen receptor.17
The crude extracts from all 4 species, and their fractions, 
were screened against a small range of cancer cell lines, and 
for their antimicrobial activity (Table 1). The DCM fraction 
of D. rigidula was cytotoxic against breast cancer cell 
MCF-7 possibly due to the presence of kaemferitrin 4, which 
was previously reported to have activity against the cell line 
with an half-maximal inhibitory concentration (IC50) value 
of 0.062 mM.18 The hexane and DCM fractions of H. formi-
carum inhibited lung cancer NCI-H187 cell growth and are 
likely due to the component, β-sitosterol 3 being present, as 
it was previously reported to possess the same action with an 
IC50 value of 26.45 µg/mL.
19 The DCM fraction of U. mis-
aminensis showed broad cytotoxicity against KB cell, lung 
cancer cell NCI-H187 and breast cancer cell MCF-7 with 
IC50 values of 28, 11, and 30 µg/mL, respectively. The iso-
lated constituent from this fraction, usnic acid 8, was previ-
ously reported to induce apoptosis via a reactive oxygen 
scavenger-dependent mitochondrial pathway in MCF-7 
Table 1. Bioactivity Testing Results of Crude Extracts and Their Fractions.
Species Extract
Inhibition (IC50, µg/mL)
KB cells
Lung cancer
NCI-
H187 Breast cancer MCF-7 Vero cells HSV-1 TB Pf
Drynaria rigidula Methanol - - - na na na na
n-Hexane - - - na na na na
Dichloromethane - - 18 na na na na
Ethyl acetate - - - na na na na
Residue - - - na na na na
Hynophytum 
formicarum
Methanol - - 27 - - - -
n-Hexane - 18 - 49 - - -
Dichloromethane - 35 - 49 - - -
Ethyl acetate - - - - - - -
Residue - - - - - - -
Usnea misaminensis Methanol - 31 - - - - -
n-Hexane - 48 - - - - -
Dichloromethane 28 11 30 20 - 50 -
Ethyl acetate - - - - - - -
Residue - - - - - - -
Calymperes schmidtii Methanol - 49 - - - - -
Hexane - 38 - - - - -
Dichloromethane - 20 - - 48 - -
Ethyl acetate - 49 - -- - - -
 Residue - - - - - - -
-, inactive; na, not available; HSV, Herpes simplex virus; TB, tuberculosis; Pf, Plasmodium falciparum. IC50, half-maximal inhibitory concentration;
IC50 positive control: Ellipticine = 1.47 µg/mL against KB cell, 2.47 µg/mL against lung cancer NCI-H187, 1.83 µg/mL against vero cell; Tamoxifen = 
6.13 µg/mL against breast cancer MCF-7; Mafloquine = 0.029 µg/mL against Plasmodium falciparum; Streptomycin = 0.156 µg/mL against Mycobacterium 
tuberculosis; Acyclovir = 7.86 µg/mL against HSV-1.
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cells20 . Interestingly, the DCM fraction also showed that 
anti-mycobacterium activity with usnic acid 8 was previ-
ously reported with an MIC value of 62.5 µg/mL against 
Mycobacterium tuberculosis H37Rv.21 The crude extract and 
fractions from C. schmidtii inhibited lung cancer cell growth 
and HSV-1; however, compounds 10 and 11 have previously 
been reported for anticancer and anti-viral activities.
Conclusion
Studies on 4 Indonesian epiphytic medicinal plants, D. rigid-
ula, H. formicarum, U. misaminensis, and C. schmidtii, suc-
cessfully revealed 11 major constituents. Lung cancer cells 
NCI-H187 showed sensitivity against most of the crude 
methanol extracts and their subfractions with the exception 
of D. rigidula. The dichloromethane subfraction of U. mis-
aminensis exerts cytotoxicity against KB-oral cancer cell, 
lung cancer cell NCI-H187, and breast cancer cell MCF-7.
Experimental
Plant Material
Epiphytic medicinal plant samples, D. rigudula, U. misami-
nensis, and C. schmidtii, were collected from Malabar forest 
surrounding Bondowoso, Indonesia during wet season on 
February 2010 and sample vouchers are deposited under 
accession codes DRL, UM, and BSp, respectively. 
Hynophytum formicarum was purchased from the Traditional 
Market at Klaten, Jawa Tengah-Indonesia in which the sam-
ple originated from West Papua-Indonesia. The voucher 
sample of H. formicarum was deposited under accession 
number HF. The Drynaria, Hydnophytum, and Usnea were 
identified at Faculty of Pharmacy, University of Jember 
Indonesia. The C. schmidtii was identified by Mr Heri 
Sujadmiko, a bryologist at Faculty of Biology, Gadjah Mada 
University, Indonesia. Samples were cleaned, washed, and 
cut drying under sun shade. The dried samples were then 
separately pulverized using a grinding machine.
Extraction and Constituent Isolation of Leaves of 
Drynaria rigidula
To leaf powder (500 g) was added MeOH (5.0 L) and the 
mixture stirred for 48 hours. The suspension was filtered and 
the supernatant vaccuum dried to produce crude leaves 
extract (48.1 g). Liquid-liquid fractionation from the leaves 
extract produced n-hexane (11.7307 g), DCM (2.3467 g), 
EtOAc (10.8527 g), and residual (22.9089 g) fractions.
The hexane fraction was prepared for gas chromatogra-
phy mass spectrometry (GC-MS) analysis with samples (5 
mg/mL) prepared by treating the solution with BSTFA (N,O-
bis(trimetylsilyl)trifluoroacetamide) for 12 hours. The 
trimethylsilyl derivatives were then subjected to GC-MS and 
the resulting spectra compared with spectra in the NIST08 
database. This revealed 3 major secondary metabolites, 
namely campesterol 1, stigmasterol 2, and β-sitosterol 3. The 
DCM fraction (1.8755 g) was subjected to a silica gel col-
umn chromatography plug (2 × 30 cm) and gradient elution 
with n-hexane, transitioning to EtOAc and EtOAc to ACN to 
produce 122 fractions. Analysis by thin-layer chromatogra-
phy (TLC) allowed sample pooling to produce 13 fractions. 
The subfraction 10 (150 mg) was loaded into a short 
RP-column (1.5 × 3.0 cm) and washed with MeOH (50 mL) 
and EtOAc (100 mL). The relevant fraction(s) were then 
concentrated to 10 mL and subjected to semipreparative 
HPLC with a gradient elution from 100% to 50% of solvent 
A within 40 minutes (solvent A: 0.1% TFA in H2O; solvent 
B: 0.1% TFA in ACN) to yield kaempferol-7-O-α-l-rhamno-
pyranosyl-4′-O-glucopyranoside 5 (20 mg). The EtOAc frac-
tion (350 mg) was subjected to short silica gel column 
chromatography (2 cm × 5 cm) and elution with 
ACN:MeOH:H2O (8:1:1) produced a 200 mL fraction, which 
was concentrated to 7 mL. The sample was then injected in 7 
blocks in preparative HPLC with a gradient elution from 
100% to 80% solvent A (0.1% TFA in H2O) in 40 minutes 
with solvent B (0.1% TFA in acetonitrile) to produce kaemp-
feritrin 4 (100 mg) and kaempferol-7-O-α-l-rhamnopyrano-
syl-4′-O-glucopyranoside 5 (28 mg).
Extraction and Constituent Isolation of Hydnophytum 
formicarum
A suspension of the whole plant powder (600 g) in MeOH (5.0 
L) was stirred for 24 hours, filtered, and the supernatant vac-
cuum dried to produce dried extract (36.2 g). A portion of dried 
extract (10 g) was fractionated with n-hexane (601.0 mg), 
DCM (150.5 mg), EtOAc (3453.8 mg), and residue (3029.7 
mg). The n-hexane fraction (601.0 mg) was subjected to flash 
silica column chromatography (2-cm diameter, 30-cm length) 
and elution starting with n-hexane, transitioning to n-hexane 
(0.2 L), n-hexane:EtOAc (9.5:0.5, 0.5 L), n-hexane:EtOAc 
(9:1, 0.1 L), n-hexane:EtOAc (8.5:1.5, 0.4 L), n-hexane:EtOAc 
(8:2, 0.3 L), n-hexane:EtOAc (7.5:2.5, 0.2 L), n-hexane:EtOAc 
(5:5, 0.1 L), n-hexane:EtOAc (2.5:7.5, 0.1 L), EtOAc (100 L), 
EtOAc:ACN (5:5, 0.1 L), ACN (0.1 L), ACN:MeOH:H2O 
(9:0.5:0.5, 0.1 L), and ACN:MeOH:H2O (8:1:1, 0.1 L) to pro-
duce 110 fractions. TLC analysis of the fractions allowed isola-
tion of crystals of compound 6 (4.1 mg) from fractions 16 and 
17, and crystals of compound 3 (51.0 mg) from fractions 22 to 
27. Fractions 39 to 42 were pooled and subjected to silica gel 
column chromatography (0.5-cm diameter, 6-cm length) and 
elution with EtOAc produced compound 7 (3.1 mg).
Extraction and Constituent Isolation of Usnea 
misaminensis
Dried powder (200 g) was stirred with MeOH for 48 hours at 
room temperature and then filtered and the supernatant vac-
cuum dried to produce crude extract (16.6 g). Liquid-liquid 
fractionation of the rhizome extract produced n-hexane (1.28 
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g), DCM (3.26 g), and EtOAc (4.81 g), fractions along with 
a residue (1.45 g). The n-hexane fraction (0.2 g) was sub-
jected to a short C18 column (2 × 4 cm) and eluted with 
EtOAc. To this EtOAc fraction was added dropwise water 
and the resulting precipitate was collected, vacuum dried, 
and redissolved in DCM (2 mL) and left allowing the forma-
tion of yellow crystals of usnic acid 8 (60.5 mg). The DCM 
fraction (1 g) was subjected to short silica gel column chro-
matography (2 × 15 cm) and elution with n-hexane gave sal-
azinic acid 9 (650 mg). The EtOAc fraction (0.5 g) was 
prepared for HPLC analysis by filteration through a short C18 
column (5 mL) and elution with DCM (100 mL) and 
MeOH:ACN (1:1, 100 mL) and concentrated to 25 mL. 
Preparative HPLC was employed with a gradient elution 
from 80% into 50% solvent A (0.1% TFA in H2O) within 50 
minutes with solvent B (0.1% TFA in ACN). The fraction 
collected at tR 25 minutes was allowed to stand and needle 
crystals formed, identified as salazinic acid 9 (44.1 mg) by 
X-ray crystallographic analysis.
Crystallographic Data of Compound 8 (Usnic Acid)
Crystal data. Compound 8. C18H12O10•H2O, M = 406.30, T 
= 150K, monoclinic, space group P21/c, Z = 4, a = 
21.5208(11), b = 4.09693(14), c = 19.0128(7)Å, β = 
103.744(5)°, V = 1628.33(12) Å3, Dx = 1.657 g/cm
3, Cu Kα 
radiation, λ = 1.54180 Å, 15 785 reflections measured (2θ 
= 4–140°) merged to 3 046 unique data, R = 0.043 [for 
2547 data with I > 2σ(I)], Rw = 0.104 [all data], S = 1.02. 
Structure determination of compound 8. Images were mea-
sured on an Agilent SuperNova diffractometer (Cu Kα 
radiation, mirror monochromator, λ = 1.54180 Å) and data 
extracted using the CrysAlis PRO package.22 Structure 
solution was by direct methods (SIR92).23 The structure 
was refined using the CRYSTALS program package.24 
Atomic coordinates, bond lengths and angles, and dis-
placement parameters have been deposited at the 
Cambridge Crystallographic Data Centre (CCDC no. 
1567131). These data can be obtained free-of-charge via 
www. ccdc. cam. ac. uk/ data_ requerst/ cif, by emailing  data_ 
request@ ccdc. cam. ac. uk, or by contacting The Cambridge 
Crystallographic Data Centre, 12 Union Road, Cambridge 
CB2 1EZ, UK; fax: +44 1223 336033.
Crystallographic Data of Compound 9 (Salazinic 
Acid)
Crystal data. Compound 9. C18H16O7, M = 344.32, T = 200 
K, orthorhombic, space group P212121, Z = 8, a = 8.0273(1), 
b = 18.9068(3), c = 20.2525(3)Å, V = 3073.73(8)Å3, Dx = 
1.488 g/cm3, Mo Kα radiation, λ = 0.71073 Å, 43 467 reflec-
tions measured (2θ = 6–60°) merged to 5 024 unique data, R 
= 0.034 (for 4 436 data with I > 2σ(I)), Rw = 0.087 (all data), 
S = 0.99. Structure determination of compound 9. Images 
were measured on a Nonius KappaCCD diffractometer (Mo 
Kα radiation, graphite monochromator, λ = 0.71073 Å) and 
data extracted using the DENZO package.25 Structure solu-
tion was by direct methods (SIR92).23 The structure was 
refined using the CRYSTALS program package.24 Atomic 
coordinates, bond lengths and angles, and displacement 
parameters have been deposited at the Cambridge 
Crystallographic Data Centre (CCDC no. 1567130).
Extraction and Constituent Isolation of Calymperes 
schmidtii
A suspension of powdered of C. schmidtii whole plant (20 g) 
in MeOH (1 L) was stirred for 24 hours, filtered, and the fil-
trate concentrated to produce a dark green sticky semisolid 
(1.1 g). The crude extract in MeOH (100 mL) was liquid-liq-
uid partitioned with n-hexane and both fractions were sepa-
rately concentrated to produce an n-hexane fraction (360 
mg) and a MeOH fraction (769 mg). A portion of the metha-
nol fraction (250 mg) was applied into a short C18 silica col-
umn (1.5 × 5 cm) and was then eluted with MeOH (50 mL) 
to give a solution, which was concentrated to 20 mL and fil-
tered through a HPLC sample filter (0.45 µm). Analysis by 
HPLC using a gradient elution from 100% of solvent A 
(0.1% TFA in H2O) to 0% of solvent A within 80 minutes 
(solvent B, 0.1% TFA in ACN) separated compounds 10 and 
11 at retention times 39 and 45 minutes, respectively. Both 
fractions were vacuum dried to give pale yellow solids, 
methyl 2,4-dihydroxy-3,6-dimethyl-benzoate 10, and methyl 
2,4-dihydroxy-6-methylbenzoate 11.
Bioactivity Testing
Antimalarial activity was determined against Plasmodium 
falciparum K1 based on the microculture radioisotope 
technique.26 Cytotoxicity was tested against KB-oral can-
cer cell, lung cancer cell NCI-H187, breast cancer cell 
MCF7, and vero cells based on the resazurin microplate 
assay. The anti-TB assay utilized the Mycobacterium 
tuberculosis H37Ra strain using a green fluorescent pro-
tein microplate assay. Antiviral activity was tested against 
herpes simplex virus type 1 using a green fluorescent pro-
tein assay.27
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